Jennison Associates
ACOR

Jennison Associates’s Acorda Therapeutics ACOR Stock Holding History

Jennison Associates’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,018
Closed -$6.4M – 667
2016
Q1 		$6.4M Sell
2,018
-748
-27% -$3.11M 0.01% 481
2015
Q4 		$14.2M Buy
+2,766
New +$12.1M 0.01% 456
2015
Q3 		– Sell
-2,252
Closed -$9.01M – 781
2015
Q2 		$9.01M Sell
2,252
-1,060
-32% -$4.09M 0.01% 518
2015
Q1 		$13.2M Buy
3,312
+7
+0.2% +$32.1K 0.01% 480
2014
Q4 		$16.2M Sell
3,305
-194
-6% -$833K 0.02% 455
2014
Q3 		$14.2M Buy
3,499
+3
+0.1% +$11.3K 0.01% 465
2014
Q2 		$14.1M Buy
+3,496
New +$14.3M 0.01% 458

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates's ACOR Position: Q2 2016 in Review

Jennison Associates sold out of Acorda Therapeutics (ACOR) in Q2 2016, closing a stake of 2,018 shares — an estimated $6.4M sold.

Jennison Associates first reported a position in ACOR in Q2 2014 and held it in 7 quarters. The position peaked at $16.2M in Q4 2014. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2016.

  • Jennison Associates reported no remaining Acorda Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Jennison Associates sold 2,018 Acorda Therapeutics shares in Q2 2016, an estimated $6.4M.
  • Jennison Associates first reported a position in Acorda Therapeutics in Q2 2014 and held it in 7 quarters.
  • Jennison Associates's Acorda Therapeutics position peaked at $16.2M in Q4 2014.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2016.

Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.